Skip to main content
logo
Jeil Pharma Holdings Inc (KRX:002620)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,210.00
-170.00 (-2.66%)
Last updated: Jul 14, 2026, 2:00 PM KST

Jeil Pharma Holdings Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
97,480123,423120,046180,683236,407245,618
Market Cap Growth
-24.31%2.81%-33.56%-23.57%-3.75%-24.53%
Enterprise Value
338,500363,252328,142429,021424,544404,795
Last Close Price
6350.008040.007753.0811596.1615107.7715636.92
PE Ratio
7.268.43----
PS Ratio
0.160.190.150.230.300.32
PB Ratio
0.210.260.270.450.560.49
P/TBV Ratio
0.310.400.400.670.910.96
P/FCF Ratio
39.49-593.17---
P/OCF Ratio
8.19316.2626.43--18.33
EV/Sales Ratio
0.540.550.420.530.540.53
EV/EBITDA Ratio
6.596.74112.4612.82126.4648721.60
EV/EBIT Ratio
9.329.32-20.51--
EV/FCF Ratio
137.12-1621.42---
Debt / Equity Ratio
0.360.360.360.530.390.23
Debt / EBITDA Ratio
3.333.1053.196.4048.4413850.20
Debt / FCF Ratio
68.32-766.93---
Net Debt / Equity Ratio
0.180.190.180.390.260.14
Net Debt / EBITDA Ratio
1.691.6327.194.6332.538166.30
Net Debt / FCF Ratio
34.56-11.16391.98-14.57-3.34-6.60
Asset Turnover
0.720.740.880.920.900.86
Inventory Turnover
3.143.334.614.945.384.88
Quick Ratio
0.810.760.730.610.650.71
Current Ratio
1.221.161.080.930.981.13
Return on Equity (ROE)
7.51%7.64%-15.82%-3.22%-18.07%-2.57%
Return on Assets (ROA)
2.54%2.76%-0.79%1.50%-0.54%-0.63%
Return on Invested Capital (ROIC)
5.68%6.39%-2.08%3.85%-1.38%-1.51%
Return on Capital Employed (ROCE)
6.30%7.00%-2.20%4.50%-1.50%-1.50%
Earnings Yield
13.79%11.86%-42.62%-8.99%-31.54%-1.42%
FCF Yield
2.53%-6.40%0.17%-5.89%-13.84%-4.19%
Dividend Yield
0.78%--0.43%0.33%0.42%
Payout Ratio
1.36%1.25%----
Buyback Yield / Dilution
-0.13%-0.01%0.01%---
Total Shareholder Return
0.62%-0.01%0.01%0.43%0.33%0.42%